Doheny Eye Institute
Trevor Nash is an experienced professional in the field of ocular disease evaluation, currently serving as an Ocular Disease Evaluator I at Doheny Eye Institute since November 2019. Prior to this role, Trevor held positions as a Junior Engineer at AdTech Photonics from March 2018 to March 2019 and as a Polymer Chemist at Wavefront Technology from September 2017 to February 2018. Trevor earned a Bachelor of Arts in Chemistry from Occidental College, attending from 2013 to 2017, and completed a High School Diploma at South Pasadena Senior High School in 2013.
Doheny Eye Institute
Doheny Eye Institute is an independent, non-profit organization whose mission is to further the conservation, improvement and restoration of human eyesight. Mrs. Carrie Estelle Doheny, wife of the prominent Los Angeles oilman Edward L. Doheny, lost the sight in her left eye at the age of 69. Suddenly aware of the precious and delicate nature of the gift of sight, in 1947 Mrs. Doheny created the organization named for her. Today, the Doheny Eye Institute serves thousands of patients in clinics around Los Angeles and Orange Counties and has emerged as a world leader in basic and clinical vision research and advanced patient care. The Institute's innovative research programs continually result in new diagnostic and treatment procedures and are respected internationally for research of the highest caliber, with direct impact on changing lives with improved sight In December 2013, UCLA’s Stein Eye Institute and the Doheny Eye Institute signed a long-term affiliation agreement. Under terms of the affiliation agreement there is a single integrated UCLA Department of Ophthalmology underlying both Institutes comprising Doheny-affiliated physicians and Stein physicians. The clinical enterprise will function as a single entity. Patients will encounter the same patient experience and range of services at any of the locations. Resources of both institutes will be dedicated to preeminence in patient care, research and education and will benefit the faculty of the UCLA Department of Ophthalmology.